Proteomics Research and Development company, CDI Laboratories, has created glass slide substrates printed with recombinant human proteins comprising 81% of the human proteome for high-throughput ...
Decision Biomarkers Inc (DBI) has announced the company's PATH® technology has been awarded United States Patent 7,297,497 by the U.S. Patent and Trademark Office. The patent applies to a novel, ultra ...
Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...
Multi-center Phase I clinical study will evaluate the safety and tolerability of a monovalent strain of avian influenza A (H7N9) vaccine delivered intradermally by Vaxxas’ high-density microarray ...
Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch” technology and utilizes Micron's first-in-class dissolvable microarray technology Research builds on Emory's ...
The MarketWatch News Department was not involved in the creation of this content. -- Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch" technology and utilizes ...
Dublin, May 15, 2024 (GLOBE NEWSWIRE) -- The "Global Microarray Analysis Market - A Global and Regional Analysis: Focus on Product, Type, Application, End User, Region, Country Level Analysis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback